RxDoctor Payments Data

Odalys Carrion, MD

General Practice · Anasco, PRNPI 1316294259

Payments from drug & device makers

$480in general payments, 2019–2025

Across 23 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$99
  • Novo Nordisk$85
  • Bayer$83
  • Amarin Pharma, Inc.$61
  • Lilly USA, LLC$60
  • Pfizer$50
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$480 in reported general payments places this provider in the 70th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$2,803
Medicare patients
11
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide103$127,374
EliquisApixaban83$93,699
OzempicSemaglutide55$79,392
JardianceEmpagliflozin47$75,367
JanuviaSitagliptin Phosphate48$68,299
FarxigaDapagliflozin Propanediol38$48,942
TradjentaLinagliptin26$38,102
XareltoRivaroxaban23$33,372
EntrestoSacubitril/Valsartan23$29,287
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$28,573
LinzessLinaclotide32$24,732
VascepaIcosapent Ethyl20$15,378
Lantus SolostarInsulin Glargine,hum.Rec.Anlog110$14,540
JanumetSitagliptin Phos/Metformin Hcl12$14,480
Breo ElliptaFluticasone/Vilanterol31$12,443

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Humulin 70-30$60$129,764115 claims
PfizerEliquis$50$93,69983 claims
Novo NordiskOzempic$85$79,39255 claims
AstraZenecaFarxiga, Symbicort$13$56,69761 claims
GSKTrelegy Ellipta, Breo Ellipta$99$41,01766 claims
Sanofi-aventis U.S. LLCLantus$14$2,27621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Anasco

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →